Related Topics News - Drugs

     
 Title only   |   Print    Next page > 
     
《大行》大摩:中國AI藥物研發融資加速 金斯瑞受惠濕實驗室需求

2026-11-09T  
石藥兩項臨床試驗在內地啟動首個研究中心

2026-11-09T  
中生製藥公布TQ-A3334二期臨床數據

2026-11-09T  
《大行》大華繼顯升中生製藥目標價至7.5元 70億美元合作料推動明年增長

2026-11-06T  
神威藥業首九個月營業額按年減少28.3%

2026-11-06T  
石四藥集團三個產品取得國家藥監局藥品生產註冊批件

2026-11-05T  
《大行》華泰:金斯瑞受惠AIDD 上調盈測重申「買入」

2026-11-05T  
遠大醫藥眼科新藥CBT-001三期臨床試驗達主要終點

2026-11-05T  
聯邦制藥司美格魯肽注射液獲受理上市註冊

2026-11-05T  
中生製藥與勃林格殷格翰達成合作 潛在收款70億美元

2026-11-04T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.